SUMO融合技术与传统基因融合系统的比较:SUMO增强表达和溶解性。
Comparison of SUMO fusion technology with traditional gene fusion systems: enhanced expression and solubility with SUMO.
作者信息
Marblestone Jeffrey G, Edavettal Suzanne C, Lim Yiting, Lim Peter, Zuo Xun, Butt Tauseef R
机构信息
LifeSensors Inc., 271 Great Valley Parkway, Malvern, PA 19355, USA.
出版信息
Protein Sci. 2006 Jan;15(1):182-9. doi: 10.1110/ps.051812706. Epub 2005 Dec 1.
Despite the availability of numerous gene fusion systems, recombinant protein expression in Escherichia coli remains difficult. Establishing the best fusion partner for difficult-to-express proteins remains empirical. To determine which fusion tags are best suited for difficult-to-express proteins, a comparative analysis of the newly described SUMO fusion system with a variety of commonly used fusion systems was completed. For this study, three model proteins, enhanced green fluorescent protein (eGFP), matrix metalloprotease-13 (MMP13), and myostatin (growth differentiating factor-8, GDF8), were fused to the C termini of maltose-binding protein (MBP), glutathione S-transferase (GST), thioredoxin (TRX), NUS A, ubiquitin (Ub), and SUMO tags. These constructs were expressed in E. coli and evaluated for expression and solubility. As expected, the fusion tags varied in their ability to produce tractable quantities of soluble eGFP, MMP13, and GDF8. SUMO and NUS A fusions enhanced expression and solubility of recombinant proteins most dramatically. The ease at which SUMO and NUS A fusion tags were removed from their partner proteins was then determined. SUMO fusions are cleaved by the natural SUMO protease, while an AcTEV protease site had to be engineered between NUS A and its partner protein. A kinetic analysis showed that the SUMO and AcTEV proteases had similar KM values, but SUMO protease had a 25-fold higher kcat than AcTEV protease, indicating a more catalytically efficient enzyme. Taken together, these results demonstrate that SUMO is superior to commonly used fusion tags in enhancing expression and solubility with the distinction of generating recombinant protein with native sequences.
尽管有众多基因融合系统可供使用,但在大肠杆菌中表达重组蛋白仍然困难。为难以表达的蛋白质确定最佳融合伴侣仍然是凭经验的。为了确定哪些融合标签最适合难以表达的蛋白质,我们完成了对新描述的SUMO融合系统与多种常用融合系统的比较分析。在本研究中,三种模型蛋白,即增强型绿色荧光蛋白(eGFP)、基质金属蛋白酶-13(MMP13)和肌肉生长抑制素(生长分化因子-8,GDF8),被融合到麦芽糖结合蛋白(MBP)、谷胱甘肽S-转移酶(GST)、硫氧还蛋白(TRX)、NUS A、泛素(Ub)和SUMO标签的C末端。这些构建体在大肠杆菌中表达,并对其表达和溶解性进行评估。正如预期的那样,融合标签在产生可处理量的可溶性eGFP、MMP13和GDF8的能力方面各不相同。SUMO和NUS A融合最显著地增强了重组蛋白的表达和溶解性。然后确定了SUMO和NUS A融合标签从其伴侣蛋白上移除的难易程度。SUMO融合蛋白被天然SUMO蛋白酶切割,而必须在NUS A与其伴侣蛋白之间设计一个AcTEV蛋白酶位点。动力学分析表明,SUMO蛋白酶和AcTEV蛋白酶具有相似的KM值,但SUMO蛋白酶的kcat比AcTEV蛋白酶高25倍,表明其催化效率更高。综上所述,这些结果表明,SUMO在增强表达和溶解性方面优于常用的融合标签,其区别在于能产生具有天然序列的重组蛋白。